DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Dubey D, Cano CA, Stüve O.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
Curr Opin Neurol 2016;
29: 278-285
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.